Has Craig Henry received payments from drug or device companies?

Yes. Drug and device makers reported $5,350 in general payments to Craig Henry across 293 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Craig Henry did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Craig Henry come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Craig Henry

Internal Medicine · Arlington, TXNPI 1619011988

Payments from drug & device makers

$5,350in general payments, 2019–2025

Across 293 payments — averaging $18.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$724
Viiv Healthcare Company$539
Baxter Healthcare$421
AstraZeneca$408
Amarin Pharma, Inc.$382
Amgen$380
plus $2K from 32 others

What the payments were for

Food & beverage$4,89992%
Education$301%
Other$4218%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	44	$724
Viiv Healthcare Company	35	$539
Baxter Healthcare	1	$421
AstraZeneca	20	$408
Amarin Pharma, Inc.	11	$382
Amgen(2 entities)	25	$380
Gilead	13	$238
Lilly USA, LLC	12	$213
Novo Nordisk	12	$173
Clarus Therapeutics Inc.	7	$155
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	10	$151
Esperion Therapeutics, Inc.	8	$150
Takeda Pharmaceuticals U.S.A., Inc.	14	$149
Boehringer Ingelheim	7	$128
Johnson & Johnson	8	$120
Currax Pharmaceuticals LLC	9	$118
Upsher-smith Laboratories LLC	6	$111
Supernus Pharmaceuticals, Inc.	8	$106
Antares Pharma, Inc.	6	$97
Merck	7	$97
Eisai Inc.	5	$76
Sanofi-aventis U.S. LLC	3	$50
Kowa Pharmaceuticals America, Inc.	3	$45
IBSA Pharma Inc.	2	$39
EMD Serono, Inc.	2	$38
Vivus LLC	2	$30
Kyowa Kirin, Inc.	1	$28
Teva Pharmaceuticals USA, Inc.	2	$25
Lundbeck LLC	1	$22
Arbor Pharmaceuticals, Inc.	1	$18
Jazz Pharmaceuticals Inc.	1	$18
Biohaven Pharmaceuticals, Inc.	1	$17
Adlon Therapeutics L.p.	1	$16
Ironwood Pharmaceuticals, Inc	1	$16
Genentech USA, Inc.	1	$15
MDD US Operations, LLC	1	$12
Alkermes, Inc.	1	$12
Theratechnologies Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

JATENZO$362
Vascepa$250
UBRELVY$104

How this compares

$5,350 in reported general payments places this provider in the 85th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas →

Other internal medicine in Arlington

Jan BurgerHouston$47.3M
Nitin JainHouston$33.2M
Muhammad IrfanTomball$30.6M
Aung NaingHouston$30.6M
Robert BassSan Antonio$25.6M
Preetesh JainHouston$19.5M
Paolo StratiHouston$19.2M
Hernan SalazarSan Antonio$18.5M
Nicholas ShortHouston$17.6M
Salma SaigerMesquite$16.1M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →